INTU stock declined approximately -12% over the past 30 days, driven by sector-wide concerns over AI disruption and valuation compression in software stocks. Over the past quarter, the stock fell around -36%, reflecting broader market rotation away from high-growth tech names amid slowing growth expectations.

GLW stock rose approximately +19% over the past 30 days amid volatility, driven by AI data center demand and analyst upgrades. Over the past quarter, shares surged +67%, fueled by a major Meta partnership and strong Q4 2025 earnings beat with upbeat guidance.

MAXN stock declined approximately -54% over the past 30 days amid a severe liquidity crisis, culminating in the company's April 1 application for judicial management in Singapore. Over the past quarter, the stock fell around -65%, driven by sharp revenue contraction, ongoing U.

BSX stock declined approximately -15% over the past 30 days amid concerns over slowing growth in key segments like electrophysiology (EP, treatments for heart rhythm disorders) and WATCHMAN devices, triggered by analyst downgrades and mixed clinical trial data. Over the past quarter, shares fell around -35%, reflecting post-earnings reactions to softer 2026 guidance despite Q4 2025 beats on revenue and EPS.

MCK stock declined -8% over the past 30 days amid analyst price target adjustments and concerns over GLP-1 drug pricing pressures, despite solid fundamentals. Over the past quarter, the stock rose +3%, supported by strong Q3 fiscal 2026 earnings that beat estimates and raised full-year guidance.

CISO stock declined approximately -14% over the past 30 days, reflecting post-earnings weakness and ongoing profitability concerns despite loss narrowing. Over the past quarter, shares fell around -25%, driven by revenue declines and liquidity risks highlighted in recent SEC filings.

RELX stock declined approximately -6% over the past 30 days, reflecting ongoing concerns over AI disruption in its core information analytics businesses. Over the past quarter, the stock fell around -15%, driven by a sharp selloff following Anthropic's AI tool launch targeting legal and data workflows.

TME stock declined -34% over the past 30 days, primarily triggered by a sharp post-earnings drop after Q4 2025 results revealed declining monthly active users (MAUs). Over the past quarter, the stock fell -44%, reflecting broader concerns over user growth slowdown and competition in China's music streaming market.

MESO stock declined approximately -15% over the past 30 days amid profit-taking following strong Ryoncil sales reports and broader biotech sector volatility. Over the past quarter, the stock is down around -30%, reflecting a pullback from January highs despite positive revenue growth from its lead product Ryoncil.

BON stock declined approximately -12% over the past 30 days, reflecting ongoing volatility in the specialty chemicals sector and limited market reaction to recent partnerships. Over the past quarter, the stock fell around -23%, amid broader downward pressure from weak revenue growth reported in interim results and thin trading volumes.

APP stock declined approximately -13% over the past 30 days, reflecting heightened market volatility and sector rotation away from high-growth tech names. Over the past quarter, the stock fell around -35%, amid broader tech pullbacks despite solid fundamentals in AI-driven advertising.

HDB stock declined -13% over the last 30 days amid governance concerns triggered by the abrupt resignation of part-time chairman Atanu Chakraborty over ethical differences. Over the past quarter, shares fell -23%, reflecting post-merger integration challenges, deposit mobilization pressures, and broader Indian banking sector headwinds.

QCOM stock declined approximately -9% over the past 30 days, driven primarily by analyst downgrades and ongoing concerns over smartphone demand weakness amid global memory shortages. Over the past quarter, the stock fell around -30%, reflecting post-earnings sell-offs after weak guidance and broader sector pressures in semiconductors.

Citigroup (C) stock rose approximately +9% over the past 30 days, driven by positive analyst price target increases and anticipation of strong Q1 earnings. Over the past quarter, the stock declined -4%, reflecting pullback from February highs amid regulatory concerns and broader market volatility in banking sector.

PBR stock rose +18.5% over the last 30 days, propelled by surging global oil prices above $110 per barrel and record production levels. Over the past quarter, shares gained +80%, driven by robust Q4 2025 earnings, increased oil output, and substantial dividend payouts.

TECS gained approximately +10% over the last 30 days, driven by a pullback in the underlying Technology Select Sector Index amid geopolitical tensions and sector rotation. Over the past quarter, TECS rose +20%, reflecting approximately -3x the inverse performance of the technology sector's -7% decline.

XLC rose approximately +3.5% over the last 30 days, recovering from late-March lows amid a rebound in top holdings like Meta Platforms and Alphabet following AI capex concerns. Over the past quarter, the ETF declined -4.9%, reflecting weak sector performance driven by media and entertainment losses offset partially by telecom gains.

Completion of Corpus Christi Stage 3 trains in 2026 to add over 10 million tonnes per annum (MTPA) of LNG capacity, boosting production to approximately 52 MTPA. Upsized $10 billion share repurchase program through 2030, targeting run-rate distributable cash flow (DCF) of $30 per share post-buybacks and initial expansion FIDs.

Chevron targets 2-3% annual production growth through 2030, driven by Permian Basin stability, Guyana expansions via Hess integration, and Tengizchevroil (TCO) project ramp-ups. Analyst consensus leans "Buy" or "Hold" with average 12-month price targets around $187-$205, reflecting optimism on free cash flow (FCF) growth at $70 Brent crude.

From what I see on the chart of AXP , there's a neutral short-term trend playing out within a broader downtrend that's developed over the past quarter. Shares have fallen about -17% year-to-date from a 52-week high near $387, and now they're trading around $305-$306 in a consolidation phase over the last 30 days, posting a modest 1.7% gain. The price action is forming higher lows in what looks like an impulsive structure, but the inability to reclaim longer-term moving averages points to ongoing bearish pressure. One thing that stands out is the key upward-sloping weekly trendline from October 2023, which has acted as support on three occasions now—the current test near $300 is something I'm watching closely for potential bounces, as we've seen before.